Irf-1 inhibits angiogenic activity of hpv16 e6 oncoprotein in cervical cancer

Pharmacology, Toxicology and Pharmaceutical Science

• Interferon Regulatory Factor 1 100%
• Protein E6 100%
• Uterine Cervix Cancer 100%
• Human Papillomavirus Type 16 100%
• Human Papillomavirus 8%
• Virus Infection 8%
• Growth Inhibitor 8%
• Vasculotropin Receptor 2 8%

Immunology and Microbiology

• Human Papillomavirus Type 16 100%
• Interferon Regulatory Factor 1 100%
• Cell Proliferation 16%
• Angiogenesis 16%
• P53 16%
• Cell Growth 16%
• Cell Migration 8%
• Immune Response 8%
• Promoter Region 8%
• Transcription Factors 8%
• Vasculotropin 8%
• Viral Disease 8%
• Cell Viability 8%

Biochemistry, Genetics and Molecular Biology

• Human Papillomavirus Type 16 100%
• Cell Proliferation 16%
• Angiogenesis 16%
• Carcinogenesis 16%
• P53 16%
• P21 16%
• Cell Growth 16%
• Immunoglobulin Enhancer Binding Protein 16%
• Cell Migration 8%
• Immune Response 8%
• Promoter Region 8%
• Transcription Factors 8%
• Vascular Endothelial Growth Factor 8%
• Growth Inhibition 8%
• Small Interfering RNA 8%
• Tumor Progression 8%